Skip to main content

Advertisement

Log in

The rationale for third trimester testing of vertical HIV transmission in neonates with CMV infection

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

We report on a late-preterm neonate with severe congenital cytomegalovirus (CMV) infection, refractory to antiviral therapy with ganciclovir. Subsequent immune diagnostics led to the finding of HIV infection at day 69, even though the mother tested negative for HIV in early pregnancy. Thus, in congenital CMV infection, HIV testing should be performed to elucidate maternal HIV seroconversion during late pregnancy. Our case strongly supports third trimester screening of HIV infection acquired during pregnancy, yet recommended only for women with traditional risk factors for HIV or living in an area of high HIV prevalence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.

    Article  PubMed  Google Scholar 

  2. Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46:22–6.

    Article  Google Scholar 

  3. Kimberlin DW, Acosta EP, Sánchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–45.

    Article  CAS  PubMed  Google Scholar 

  4. Cremer M, Weimann A, Schmalisch G, et al. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia. Thromb Haemost. 2010;103:1016–21.

    Article  CAS  PubMed  Google Scholar 

  5. Roux W, Pieper C, Connon M. Thrombocytopenia as marker for HIV exposure in the neonate. J Trop Pediatr. 2001;47:208–10.

    Article  CAS  PubMed  Google Scholar 

  6. Duryea EL, Sánchez PJ, Sheffield JS, et al. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J. 2010;29:915–8.

    Article  PubMed  Google Scholar 

  7. Mwaanza N, Chilukutu L, Tembo J, et al. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis. 2014;58:728–35.

    Article  PubMed  Google Scholar 

  8. Frederick T, Homans J, Spencer L, et al. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012;55:877–84.

    Article  CAS  PubMed  Google Scholar 

  9. Moses SE, Tosswill J, Sudhanva M, et al. HIV-1 seroconversion during pregnancy resulting in vertical transmission. J Clin Virol. 2008;41:152–3.

    Article  CAS  PubMed  Google Scholar 

  10. Roongpisuthipong A, Siriwasin W, Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr. 2001;26:348–51.

    Article  CAS  PubMed  Google Scholar 

  11. Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2012;59:417–25.

    Article  PubMed  PubMed Central  Google Scholar 

  12. De Schacht C, Hoffmann HJ, Mabunda N, et al. High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study. PLoS One. 2014;9:e115014.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Faghih S, Secord E. Increased adolescent HIV infection during pregnancy leads to increase in perinatal transmission at urban referral center. J Int Assoc Physicians AIDS Care (Chic). 2012;11:293–5.

    Article  Google Scholar 

  14. Illinois Perinatal HIV Prevention Act, P.L. 95–702 (2007). http://www.aidschicago.org/resources/legacy/pdf/2007/adv_perinatal_fact_sheet_2007_law.pdf. Accessed 30 Oct 2015.

  15. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR14):1–17.

    PubMed  Google Scholar 

  16. Committee on Obstetric Practice and HIV Expert Work Group. Committee opinion no: 635: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2015;125:1544–7.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vinzenz Boos.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boos, V., Feiterna-Sperling, C., Sarpong, A. et al. The rationale for third trimester testing of vertical HIV transmission in neonates with CMV infection. Infection 44, 555–557 (2016). https://doi.org/10.1007/s15010-016-0876-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-016-0876-0

Keywords

Navigation